Veritas Capital Buys Back into Big Data
Big data firms are sweet targets for healthcare investors. Just last February, Veritas Capital sold Truven Health Analytics to IBM Watson Health (NYSE: IBM) for $2.6 billion. Now it’s putting some of that ROI into another big data firm, Verisk Health, the healthcare service business Verisk Analytics Inc. Verisk Health provides data services, analytics and advanced technologies to help users make smarter business decisions and reduce risk. The $820 million purchase price consists of $720 million in cash and a $100 million long-term subordinated promissory note. With Truven Health Analytics, Veritas Capital repositioned the company from a data provider with limited analytics offerings... Read More »naviHealth Buys Curaspan
naviHealth is moving deeper into post-acute care transitions, in an effort to follow the bundled payments from end-to-end. Last week the company announced it will acquire Curaspan Health Group for an undisclosed amount. Just last August, naviHealth was the target in a $290 million deal, as Cardinal Health (NYSE: CAH) acquired 71% of the company from Welsh, Carson, Anderson & Stowe, with the goal of acquiring the remaining 29% within four years. naviHealth provides software and analytics to healthcare plans, health systems, physicians and post-acute care providers to manage the entire continuum of post-acute care. Curaspan Health specializes in care transition tools for hospitals and... Read More »eHealth Deals, 2006 to 2015
Merger and acquisition activity in the eHealth sector has grown since 2013. Strategic buyers such as IBM Watson Health (NYSE: IBM) made big moves into this area, and private equity investors are focusing on revenue cycle manaegment, electonic health records serving specific segments and any platform that offers better cost containment for health care providers. Read More »Leap Day Boosts February Deal Volume
It’s Leap Year, which means February was a day longer in 2016. This year, that extra day marked the announcement of seven healthcare transactions, which raised the month’s total to a healthy 113 deals. The services sectors were more active than usual, and accounted for 65% of the total. Usually, the services side makes up about 55% to 60%. Dollar volume was healthy, too, at $27.7 billion. But given the records set in 2015, February’s dollar total ended up 35% below the same month a year ago. The deals may be getting smaller, but they’re still being made. Read More »Software for Sleep Disorders Attracts $800 Million
Sleep-disordered breathing is big money. Anyone who has laid awake night after night beside a chronic snorer would pay just about anything for a bit of quiet, most likely. Enter ResMed Inc. (NYSE: RMD), which has built its business on medical devices to treat sleep-disordered breathing and respiratory care. The company has made several acquisitions over the years, predominently in the medical device sector (see chart below). Targets have ranged from the German firm MAP Medezin-Technologie, acquired in 2001, to the Chinese sleep-device maker Curative Medical, a more recent acquisition in 2015. Two recent transactions have focused on the digital side of healthcare delivery. ResMed paid an... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
